Request for Covid-19 Impact Assessment of this Report
The United States Neuropeptide Y Receptor market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Neuropeptide Y Receptor market, reaching US$ million by the year 2028. As for the Europe Neuropeptide Y Receptor landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Neuropeptide Y Receptor players cover Gila Therapeutics, Novo Nordisk, XL-protein, and Lilly Eli, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Neuropeptide Y Receptor market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Food Grade
Pharmaceutical Grade
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Medicine
Food Additives
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Gila Therapeutics
Novo Nordisk
XL-protein
Lilly Eli
Novartis
Pfizer
Merck & Co
Mannkind
Gilead Sciences
Genentech
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neuropeptide Y Receptor Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Neuropeptide Y Receptor by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Neuropeptide Y Receptor by Country/Region, 2017, 2022 & 2028
2.2 Neuropeptide Y Receptor Segment by Type
2.2.1 Food Grade
2.2.2 Pharmaceutical Grade
2.3 Neuropeptide Y Receptor Sales by Type
2.3.1 Global Neuropeptide Y Receptor Sales Market Share by Type (2017-2022)
2.3.2 Global Neuropeptide Y Receptor Revenue and Market Share by Type (2017-2022)
2.3.3 Global Neuropeptide Y Receptor Sale Price by Type (2017-2022)
2.4 Neuropeptide Y Receptor Segment by Application
2.4.1 Medicine
2.4.2 Food Additives
2.4.3 Others
2.5 Neuropeptide Y Receptor Sales by Application
2.5.1 Global Neuropeptide Y Receptor Sale Market Share by Application (2017-2022)
2.5.2 Global Neuropeptide Y Receptor Revenue and Market Share by Application (2017-2022)
2.5.3 Global Neuropeptide Y Receptor Sale Price by Application (2017-2022)
3 Global Neuropeptide Y Receptor by Company
3.1 Global Neuropeptide Y Receptor Breakdown Data by Company
3.1.1 Global Neuropeptide Y Receptor Annual Sales by Company (2020-2022)
3.1.2 Global Neuropeptide Y Receptor Sales Market Share by Company (2020-2022)
3.2 Global Neuropeptide Y Receptor Annual Revenue by Company (2020-2022)
3.2.1 Global Neuropeptide Y Receptor Revenue by Company (2020-2022)
3.2.2 Global Neuropeptide Y Receptor Revenue Market Share by Company (2020-2022)
3.3 Global Neuropeptide Y Receptor Sale Price by Company
3.4 Key Manufacturers Neuropeptide Y Receptor Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neuropeptide Y Receptor Product Location Distribution
3.4.2 Players Neuropeptide Y Receptor Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Neuropeptide Y Receptor by Geographic Region
4.1 World Historic Neuropeptide Y Receptor Market Size by Geographic Region (2017-2022)
4.1.1 Global Neuropeptide Y Receptor Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Neuropeptide Y Receptor Annual Revenue by Geographic Region
4.2 World Historic Neuropeptide Y Receptor Market Size by Country/Region (2017-2022)
4.2.1 Global Neuropeptide Y Receptor Annual Sales by Country/Region (2017-2022)
4.2.2 Global Neuropeptide Y Receptor Annual Revenue by Country/Region
4.3 Americas Neuropeptide Y Receptor Sales Growth
4.4 APAC Neuropeptide Y Receptor Sales Growth
4.5 Europe Neuropeptide Y Receptor Sales Growth
4.6 Middle East & Africa Neuropeptide Y Receptor Sales Growth
5 Americas
5.1 Americas Neuropeptide Y Receptor Sales by Country
5.1.1 Americas Neuropeptide Y Receptor Sales by Country (2017-2022)
5.1.2 Americas Neuropeptide Y Receptor Revenue by Country (2017-2022)
5.2 Americas Neuropeptide Y Receptor Sales by Type
5.3 Americas Neuropeptide Y Receptor Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuropeptide Y Receptor Sales by Region
6.1.1 APAC Neuropeptide Y Receptor Sales by Region (2017-2022)
6.1.2 APAC Neuropeptide Y Receptor Revenue by Region (2017-2022)
6.2 APAC Neuropeptide Y Receptor Sales by Type
6.3 APAC Neuropeptide Y Receptor Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Neuropeptide Y Receptor by Country
7.1.1 Europe Neuropeptide Y Receptor Sales by Country (2017-2022)
7.1.2 Europe Neuropeptide Y Receptor Revenue by Country (2017-2022)
7.2 Europe Neuropeptide Y Receptor Sales by Type
7.3 Europe Neuropeptide Y Receptor Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Neuropeptide Y Receptor by Country
8.1.1 Middle East & Africa Neuropeptide Y Receptor Sales by Country (2017-2022)
8.1.2 Middle East & Africa Neuropeptide Y Receptor Revenue by Country (2017-2022)
8.2 Middle East & Africa Neuropeptide Y Receptor Sales by Type
8.3 Middle East & Africa Neuropeptide Y Receptor Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neuropeptide Y Receptor
10.3 Manufacturing Process Analysis of Neuropeptide Y Receptor
10.4 Industry Chain Structure of Neuropeptide Y Receptor
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neuropeptide Y Receptor Distributors
11.3 Neuropeptide Y Receptor Customer
12 World Forecast Review for Neuropeptide Y Receptor by Geographic Region
12.1 Global Neuropeptide Y Receptor Market Size Forecast by Region
12.1.1 Global Neuropeptide Y Receptor Forecast by Region (2023-2028)
12.1.2 Global Neuropeptide Y Receptor Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neuropeptide Y Receptor Forecast by Type
12.7 Global Neuropeptide Y Receptor Forecast by Application
13 Key Players Analysis
13.1 Gila Therapeutics
13.1.1 Gila Therapeutics Company Information
13.1.2 Gila Therapeutics Neuropeptide Y Receptor Product Offered
13.1.3 Gila Therapeutics Neuropeptide Y Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Gila Therapeutics Main Business Overview
13.1.5 Gila Therapeutics Latest Developments
13.2 Novo Nordisk
13.2.1 Novo Nordisk Company Information
13.2.2 Novo Nordisk Neuropeptide Y Receptor Product Offered
13.2.3 Novo Nordisk Neuropeptide Y Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Novo Nordisk Main Business Overview
13.2.5 Novo Nordisk Latest Developments
13.3 XL-protein
13.3.1 XL-protein Company Information
13.3.2 XL-protein Neuropeptide Y Receptor Product Offered
13.3.3 XL-protein Neuropeptide Y Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 XL-protein Main Business Overview
13.3.5 XL-protein Latest Developments
13.4 Lilly Eli
13.4.1 Lilly Eli Company Information
13.4.2 Lilly Eli Neuropeptide Y Receptor Product Offered
13.4.3 Lilly Eli Neuropeptide Y Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Lilly Eli Main Business Overview
13.4.5 Lilly Eli Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Neuropeptide Y Receptor Product Offered
13.5.3 Novartis Neuropeptide Y Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Neuropeptide Y Receptor Product Offered
13.6.3 Pfizer Neuropeptide Y Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Merck & Co
13.7.1 Merck & Co Company Information
13.7.2 Merck & Co Neuropeptide Y Receptor Product Offered
13.7.3 Merck & Co Neuropeptide Y Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Merck & Co Main Business Overview
13.7.5 Merck & Co Latest Developments
13.8 Mannkind
13.8.1 Mannkind Company Information
13.8.2 Mannkind Neuropeptide Y Receptor Product Offered
13.8.3 Mannkind Neuropeptide Y Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Mannkind Main Business Overview
13.8.5 Mannkind Latest Developments
13.9 Gilead Sciences
13.9.1 Gilead Sciences Company Information
13.9.2 Gilead Sciences Neuropeptide Y Receptor Product Offered
13.9.3 Gilead Sciences Neuropeptide Y Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Gilead Sciences Main Business Overview
13.9.5 Gilead Sciences Latest Developments
13.10 Genentech
13.10.1 Genentech Company Information
13.10.2 Genentech Neuropeptide Y Receptor Product Offered
13.10.3 Genentech Neuropeptide Y Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Genentech Main Business Overview
13.10.5 Genentech Latest Developments
14 Research Findings and Conclusion
Table 1. Neuropeptide Y Receptor Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Neuropeptide Y Receptor Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Food Grade
Table 4. Major Players of Pharmaceutical Grade
Table 5. Global Neuropeptide Y Receptor Sales by Type (2017-2022) & (Kiloton)
Table 6. Global Neuropeptide Y Receptor Sales Market Share by Type (2017-2022)
Table 7. Global Neuropeptide Y Receptor Revenue by Type (2017-2022) & ($ million)
Table 8. Global Neuropeptide Y Receptor Revenue Market Share by Type (2017-2022)
Table 9. Global Neuropeptide Y Receptor Sale Price by Type (2017-2022) & (US$/Ton)
Table 10. Global Neuropeptide Y Receptor Sales by Application (2017-2022) & (Kiloton)
Table 11. Global Neuropeptide Y Receptor Sales Market Share by Application (2017-2022)
Table 12. Global Neuropeptide Y Receptor Revenue by Application (2017-2022)
Table 13. Global Neuropeptide Y Receptor Revenue Market Share by Application (2017-2022)
Table 14. Global Neuropeptide Y Receptor Sale Price by Application (2017-2022) & (US$/Ton)
Table 15. Global Neuropeptide Y Receptor Sales by Company (2020-2022) & (Kiloton)
Table 16. Global Neuropeptide Y Receptor Sales Market Share by Company (2020-2022)
Table 17. Global Neuropeptide Y Receptor Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Neuropeptide Y Receptor Revenue Market Share by Company (2020-2022)
Table 19. Global Neuropeptide Y Receptor Sale Price by Company (2020-2022) & (US$/Ton)
Table 20. Key Manufacturers Neuropeptide Y Receptor Producing Area Distribution and Sales Area
Table 21. Players Neuropeptide Y Receptor Products Offered
Table 22. Neuropeptide Y Receptor Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Neuropeptide Y Receptor Sales by Geographic Region (2017-2022) & (Kiloton)
Table 26. Global Neuropeptide Y Receptor Sales Market Share Geographic Region (2017-2022)
Table 27. Global Neuropeptide Y Receptor Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Neuropeptide Y Receptor Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Neuropeptide Y Receptor Sales by Country/Region (2017-2022) & (Kiloton)
Table 30. Global Neuropeptide Y Receptor Sales Market Share by Country/Region (2017-2022)
Table 31. Global Neuropeptide Y Receptor Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Neuropeptide Y Receptor Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Neuropeptide Y Receptor Sales by Country (2017-2022) & (Kiloton)
Table 34. Americas Neuropeptide Y Receptor Sales Market Share by Country (2017-2022)
Table 35. Americas Neuropeptide Y Receptor Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Neuropeptide Y Receptor Revenue Market Share by Country (2017-2022)
Table 37. Americas Neuropeptide Y Receptor Sales by Type (2017-2022) & (Kiloton)
Table 38. Americas Neuropeptide Y Receptor Sales Market Share by Type (2017-2022)
Table 39. Americas Neuropeptide Y Receptor Sales by Application (2017-2022) & (Kiloton)
Table 40. Americas Neuropeptide Y Receptor Sales Market Share by Application (2017-2022)
Table 41. APAC Neuropeptide Y Receptor Sales by Region (2017-2022) & (Kiloton)
Table 42. APAC Neuropeptide Y Receptor Sales Market Share by Region (2017-2022)
Table 43. APAC Neuropeptide Y Receptor Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Neuropeptide Y Receptor Revenue Market Share by Region (2017-2022)
Table 45. APAC Neuropeptide Y Receptor Sales by Type (2017-2022) & (Kiloton)
Table 46. APAC Neuropeptide Y Receptor Sales Market Share by Type (2017-2022)
Table 47. APAC Neuropeptide Y Receptor Sales by Application (2017-2022) & (Kiloton)
Table 48. APAC Neuropeptide Y Receptor Sales Market Share by Application (2017-2022)
Table 49. Europe Neuropeptide Y Receptor Sales by Country (2017-2022) & (Kiloton)
Table 50. Europe Neuropeptide Y Receptor Sales Market Share by Country (2017-2022)
Table 51. Europe Neuropeptide Y Receptor Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Neuropeptide Y Receptor Revenue Market Share by Country (2017-2022)
Table 53. Europe Neuropeptide Y Receptor Sales by Type (2017-2022) & (Kiloton)
Table 54. Europe Neuropeptide Y Receptor Sales Market Share by Type (2017-2022)
Table 55. Europe Neuropeptide Y Receptor Sales by Application (2017-2022) & (Kiloton)
Table 56. Europe Neuropeptide Y Receptor Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Neuropeptide Y Receptor Sales by Country (2017-2022) & (Kiloton)
Table 58. Middle East & Africa Neuropeptide Y Receptor Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Neuropeptide Y Receptor Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Neuropeptide Y Receptor Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Neuropeptide Y Receptor Sales by Type (2017-2022) & (Kiloton)
Table 62. Middle East & Africa Neuropeptide Y Receptor Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Neuropeptide Y Receptor Sales by Application (2017-2022) & (Kiloton)
Table 64. Middle East & Africa Neuropeptide Y Receptor Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Neuropeptide Y Receptor
Table 66. Key Market Challenges & Risks of Neuropeptide Y Receptor
Table 67. Key Industry Trends of Neuropeptide Y Receptor
Table 68. Neuropeptide Y Receptor Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Neuropeptide Y Receptor Distributors List
Table 71. Neuropeptide Y Receptor Customer List
Table 72. Global Neuropeptide Y Receptor Sales Forecast by Region (2023-2028) & (Kiloton)
Table 73. Global Neuropeptide Y Receptor Sales Market Forecast by Region
Table 74. Global Neuropeptide Y Receptor Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Neuropeptide Y Receptor Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Neuropeptide Y Receptor Sales Forecast by Country (2023-2028) & (Kiloton)
Table 77. Americas Neuropeptide Y Receptor Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Neuropeptide Y Receptor Sales Forecast by Region (2023-2028) & (Kiloton)
Table 79. APAC Neuropeptide Y Receptor Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Neuropeptide Y Receptor Sales Forecast by Country (2023-2028) & (Kiloton)
Table 81. Europe Neuropeptide Y Receptor Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Neuropeptide Y Receptor Sales Forecast by Country (2023-2028) & (Kiloton)
Table 83. Middle East & Africa Neuropeptide Y Receptor Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Neuropeptide Y Receptor Sales Forecast by Type (2023-2028) & (Kiloton)
Table 85. Global Neuropeptide Y Receptor Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Neuropeptide Y Receptor Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Neuropeptide Y Receptor Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Neuropeptide Y Receptor Sales Forecast by Application (2023-2028) & (Kiloton)
Table 89. Global Neuropeptide Y Receptor Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Neuropeptide Y Receptor Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Neuropeptide Y Receptor Revenue Market Share Forecast by Application (2023-2028)
Table 92. Gila Therapeutics Basic Information, Neuropeptide Y Receptor Manufacturing Base, Sales Area and Its Competitors
Table 93. Gila Therapeutics Neuropeptide Y Receptor Product Offered
Table 94. Gila Therapeutics Neuropeptide Y Receptor Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 95. Gila Therapeutics Main Business
Table 96. Gila Therapeutics Latest Developments
Table 97. Novo Nordisk Basic Information, Neuropeptide Y Receptor Manufacturing Base, Sales Area and Its Competitors
Table 98. Novo Nordisk Neuropeptide Y Receptor Product Offered
Table 99. Novo Nordisk Neuropeptide Y Receptor Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 100. Novo Nordisk Main Business
Table 101. Novo Nordisk Latest Developments
Table 102. XL-protein Basic Information, Neuropeptide Y Receptor Manufacturing Base, Sales Area and Its Competitors
Table 103. XL-protein Neuropeptide Y Receptor Product Offered
Table 104. XL-protein Neuropeptide Y Receptor Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 105. XL-protein Main Business
Table 106. XL-protein Latest Developments
Table 107. Lilly Eli Basic Information, Neuropeptide Y Receptor Manufacturing Base, Sales Area and Its Competitors
Table 108. Lilly Eli Neuropeptide Y Receptor Product Offered
Table 109. Lilly Eli Neuropeptide Y Receptor Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 110. Lilly Eli Main Business
Table 111. Lilly Eli Latest Developments
Table 112. Novartis Basic Information, Neuropeptide Y Receptor Manufacturing Base, Sales Area and Its Competitors
Table 113. Novartis Neuropeptide Y Receptor Product Offered
Table 114. Novartis Neuropeptide Y Receptor Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 115. Novartis Main Business
Table 116. Novartis Latest Developments
Table 117. Pfizer Basic Information, Neuropeptide Y Receptor Manufacturing Base, Sales Area and Its Competitors
Table 118. Pfizer Neuropeptide Y Receptor Product Offered
Table 119. Pfizer Neuropeptide Y Receptor Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 120. Pfizer Main Business
Table 121. Pfizer Latest Developments
Table 122. Merck & Co Basic Information, Neuropeptide Y Receptor Manufacturing Base, Sales Area and Its Competitors
Table 123. Merck & Co Neuropeptide Y Receptor Product Offered
Table 124. Merck & Co Neuropeptide Y Receptor Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 125. Merck & Co Main Business
Table 126. Merck & Co Latest Developments
Table 127. Mannkind Basic Information, Neuropeptide Y Receptor Manufacturing Base, Sales Area and Its Competitors
Table 128. Mannkind Neuropeptide Y Receptor Product Offered
Table 129. Mannkind Neuropeptide Y Receptor Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 130. Mannkind Main Business
Table 131. Mannkind Latest Developments
Table 132. Gilead Sciences Basic Information, Neuropeptide Y Receptor Manufacturing Base, Sales Area and Its Competitors
Table 133. Gilead Sciences Neuropeptide Y Receptor Product Offered
Table 134. Gilead Sciences Neuropeptide Y Receptor Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 135. Gilead Sciences Main Business
Table 136. Gilead Sciences Latest Developments
Table 137. Genentech Basic Information, Neuropeptide Y Receptor Manufacturing Base, Sales Area and Its Competitors
Table 138. Genentech Neuropeptide Y Receptor Product Offered
Table 139. Genentech Neuropeptide Y Receptor Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 140. Genentech Main Business
Table 141. Genentech Latest Developments
List of Figures
Figure 1. Picture of Neuropeptide Y Receptor
Figure 2. Neuropeptide Y Receptor Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neuropeptide Y Receptor Sales Growth Rate 2017-2028 (Kiloton)
Figure 7. Global Neuropeptide Y Receptor Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Neuropeptide Y Receptor Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Food Grade
Figure 10. Product Picture of Pharmaceutical Grade
Figure 11. Global Neuropeptide Y Receptor Sales Market Share by Type in 2021
Figure 12. Global Neuropeptide Y Receptor Revenue Market Share by Type (2017-2022)
Figure 13. Neuropeptide Y Receptor Consumed in Medicine
Figure 14. Global Neuropeptide Y Receptor Market: Medicine (2017-2022) & (Kiloton)
Figure 15. Neuropeptide Y Receptor Consumed in Food Additives
Figure 16. Global Neuropeptide Y Receptor Market: Food Additives (2017-2022) & (Kiloton)
Figure 17. Neuropeptide Y Receptor Consumed in Others
Figure 18. Global Neuropeptide Y Receptor Market: Others (2017-2022) & (Kiloton)
Figure 19. Global Neuropeptide Y Receptor Sales Market Share by Application (2017-2022)
Figure 20. Global Neuropeptide Y Receptor Revenue Market Share by Application in 2021
Figure 21. Neuropeptide Y Receptor Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Neuropeptide Y Receptor Revenue Market Share by Company in 2021
Figure 23. Global Neuropeptide Y Receptor Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Neuropeptide Y Receptor Revenue Market Share by Geographic Region in 2021
Figure 25. Global Neuropeptide Y Receptor Sales Market Share by Region (2017-2022)
Figure 26. Global Neuropeptide Y Receptor Revenue Market Share by Country/Region in 2021
Figure 27. Americas Neuropeptide Y Receptor Sales 2017-2022 (Kiloton)
Figure 28. Americas Neuropeptide Y Receptor Revenue 2017-2022 ($ Millions)
Figure 29. APAC Neuropeptide Y Receptor Sales 2017-2022 (Kiloton)
Figure 30. APAC Neuropeptide Y Receptor Revenue 2017-2022 ($ Millions)
Figure 31. Europe Neuropeptide Y Receptor Sales 2017-2022 (Kiloton)
Figure 32. Europe Neuropeptide Y Receptor Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Neuropeptide Y Receptor Sales 2017-2022 (Kiloton)
Figure 34. Middle East & Africa Neuropeptide Y Receptor Revenue 2017-2022 ($ Millions)
Figure 35. Americas Neuropeptide Y Receptor Sales Market Share by Country in 2021
Figure 36. Americas Neuropeptide Y Receptor Revenue Market Share by Country in 2021
Figure 37. United States Neuropeptide Y Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Neuropeptide Y Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Neuropeptide Y Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Neuropeptide Y Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Neuropeptide Y Receptor Sales Market Share by Region in 2021
Figure 42. APAC Neuropeptide Y Receptor Revenue Market Share by Regions in 2021
Figure 43. China Neuropeptide Y Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Neuropeptide Y Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Neuropeptide Y Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Neuropeptide Y Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Neuropeptide Y Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Neuropeptide Y Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Neuropeptide Y Receptor Sales Market Share by Country in 2021
Figure 50. Europe Neuropeptide Y Receptor Revenue Market Share by Country in 2021
Figure 51. Germany Neuropeptide Y Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Neuropeptide Y Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Neuropeptide Y Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Neuropeptide Y Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Neuropeptide Y Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Neuropeptide Y Receptor Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Neuropeptide Y Receptor Revenue Market Share by Country in 2021
Figure 58. Egypt Neuropeptide Y Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Neuropeptide Y Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Neuropeptide Y Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Neuropeptide Y Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Neuropeptide Y Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Neuropeptide Y Receptor in 2021
Figure 64. Manufacturing Process Analysis of Neuropeptide Y Receptor
Figure 65. Industry Chain Structure of Neuropeptide Y Receptor
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Driven by improving living standards of people and a fast-growing macro-economy, China has remained the largest beer-consuming country worldwide for the 12th consecutive year since 2003, and the largest beer-producing nation globally in the past years. This report focuses on systematic evaluation and analysis of Internal Risks (arising within the industry development itself) and External Risks (ar...
Summary Based on products type, the report describes major products type share of regional market. Products mentioned as follows: By Type Microparticulated Protein Modified Whey Protein Concentrate Others Based on region, the report describes major regions market by vendor, products and application. Regions mentioned as follows: North America Europe Asia RoW Based on application, the repor...
Summary The global Oat Protein market is estimated to reach 1.4 K MT in 2017. The objective of report is to define, segment, and project the market on the basis of type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regio...